Comments
Loading...
Telesis Bio Stock Guidance | OTC:TBIO | Benzinga
Telesis Bio issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2024 | TBIO | Telesis Bio | FY | 2023 | — | — | — | $27.50M | $27.50M | $30.00M | Get Alert |
| 02/26/2024 | TBIO | Telesis Bio | Q4 | 2023 | — | — | — | $7.00M | $7.00M | $9.50M | Get Alert |
| 11/13/2023 | TBIO | Telesis Bio | FY | 2023 | — | — | — | $28.00M | $30.00M | $33.40M | Get Alert |
| 03/21/2023 | TBIO | Telesis Bio | FY | 2023 | — | — | — | $45.00M | — | $41.70M | Get Alert |
| 01/09/2023 | TBIO | Telesis Bio | Q4 | 2022 | — | — | — | $9.00M | $9.00M | — | Get Alert |
FAQ
What is the most recent guidance for Telesis Bio (TBIO)?
There have been no specific sales or earnings guidance reported for Telesis Bio in recent months.
Browse guidance and forecast on all stocks.